Skip navigation
Skip navigation

Financial costs associated with monopolies on biologic medicines in Australia

Gleeson, Deborah; Townsend, Belinda; Lopert, Ruth; Lexchin, Joel; Moir, Hazel

Description

Objectives: The aim of the study was to estimate the potential savings to the Pharmaceutical Benefits Scheme (PBS) and the Repatriation Pharmaceutical Benefits Scheme (RPBS) in 2015–16 if biosimilar versions of selected biologic medicines (biologics) had been available and listed on the PBS. Methods: The research involved retrospective analysis of Australian Medicare expenditure data and PBS price data from 2015–16 for biologics, for which biosimilar competition may be available in future,...[Show more]

CollectionsANU Research Publications
Date published: 2019
Type: Journal article
URI: http://hdl.handle.net/1885/163748
Source: Australian Health Review
DOI: 10.1071/AH17031
Access Rights: Open Access

Download

File Description SizeFormat Image
01_Gleeson_Financial_costs_associated_2019.pdf170.66 kBAdobe PDFThumbnail


This item is licensed under a Creative Commons License Creative Commons

Updated:  22 January 2019/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator